Fresenius Medical Care to pay down term loan debt with notes proceeds

By Sara Rosenberg and Paul A. Harris

New York, Jan. 17 - Fresenius Medical Care AG & Co. plans on repaying term loan borrowings using proceeds from a $1.2 billion and €250 million senior unsecured notes offering, according to a market source.

Remaining proceeds will be used for acquisitions, including the purchase of Liberty Dialysis Holdings Inc., and for general corporate purposes.

Fresenius is a Bad Homburg, Germany-based provider of products and services for individuals undergoing dialysis.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.